机译:合理设计的风险-由α-甲基酰基辅酶A外消旋酶(AMACR; P504S)催化的3-氟-2-甲基酰基辅酶A意外地不可逆地消除氟化物
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK;
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK;
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK;
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK;
Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK;
机译:α-甲基酰基辅酶A消旋酶(AMACR):代谢酶,药物代谢物和癌症标志物P504S
机译:同位素标记底物的合成和用途,用于人α-甲基酰基-Coa消旋酶1a(amacr; P504s)的机理研究
机译:睾丸支持细胞肿瘤(未特别说明)表现出大量出血和α-甲基酰基辅酶A消旋酶(AMACR / P504S)的过度表达
机译:合理设计的风险–由α-甲基酰基辅酶A外消旋酶(AMACR; P504S)催化的3-氟-2-甲基酰基辅酶A意外地不可逆地消除氟化物